SQUAWK/NEWS
Account
Account
Menu
Live News EQUITY FLASH H impact

VBIO: AFRRI/NIAID Tests Entolimod

AFRRI/NIAID designs protocol to evaluate Valion Bio's Entolimod as treatment for GI-ARS

VBIO

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.